CD58 and myeloid sarcoma: Given the effectof interferon β (IFN- β) on CD58 expression(12), we also conducted a prospective case-onlystudy to assess the effect of the mentioned varianton the therapeutic response of MS patientsto IFN- β therapy followed for two years.